EUVIMEDEUVIMED entdecken
Crossref

Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights

Tashi Palmo, Vishwani Jamwal, Karan Goel, Anuj Kumar, Somdutt Mujwar, Yogesh P Bharitkar, Kuljit Singh iD

Medicinal Chemistry Research · 2026-08 · 35 (8) · 1529-1542

DOI: 10.1007/s00044-026-03599-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicinal Chemistry Research, online erschienen am 28.07.2026. Verfasst von Tashi Palmo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu, 180001, India. Hauptthemen laut MEDLINE: Topoisomerase II Inhibitors, DNA Gyrase, Staphylococcus aureus, Anti-Bacterial Agents. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid rise of antimicrobial resistance (AMR), marked by declining efficacy of existing antibiotics against bacterial pathogens, has become a serious global health threat. Increasing resistance in the Staphylococcus aureus pathogen urgently demands the development of effective novel antibacterial agents. In this study, we investigated the previously reported antibacterial beddomeilactone amide (3g) as a potential DNA gyrase inhibitor of S. aureus. The potent hit (3g) exhibited > 90% reduction in DNA supercoiling at an effective concentration of 100 µM. Further, computational studies including molecular docking and dynamics simulation showed that the 3g molecule exhibited a favourable binding affinity of -12.33 kcal/mol, reflecting predicted stable interactions with DNA gyrase. Moreover, Density functional theory (DFT) findings further revealed key electronic properties, frontier molecular orbitals, and chemical reactivity of the compounds. These findings underscore potent hit (3g) as a promising candidate for the development of an antibacterial agent against S. aureus by targeting DNA gyrase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Topoisomerase II InhibitorsDNA GyraseStaphylococcus aureusAnti-Bacterial AgentsAmidesMolecular Docking SimulationMicrobial Sensitivity TestsStructure-Activity RelationshipDensity Functional TheoryMolecular Dynamics SimulationMolecular Structure

Stichwörter der Autor:innen

Staphylococcus aureusAntimicrobial resistance (AMR)Beddomeilactone amideDFT studiesDNA gyraseMolecular docking

Substanzen

Topoisomerase II InhibitorsDNA GyraseAnti-Bacterial AgentsAmides

Autor:innen und Institutionen

  • Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu, 180001, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India.
  • Natural Products & Medicinal Chemistry Division, CSIR- Indian Institute of Integrative Medicine, Jammu, 180001, India. yogeshp.bharitkar@iiim.res.in.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. yogeshp.bharitkar@iiim.res.in.
  • Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu, 180001, India. singhkuljit.iiim@csir.res.in.

ORCID-Profile: Kuljit Singh

Förderung

  • Council of Scientific and Industrial Research, India

Zitieren

APA

Palmo, T., Jamwal, V., Goel, K., Kumar, A., Mujwar, S., Bharitkar, Y. P., & Singh, K. (2026). Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights. Medicinal Chemistry Research, 35(8), 1529-1542. https://doi.org/10.1007/s00044-026-03599-2

Vancouver

Palmo T, Jamwal V, Goel K, Kumar A, Mujwar S, Bharitkar YP, et al. Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights. Medicinal Chemistry Research. 2026;35(8):1529-1542. doi:10.1007/s00044-026-03599-2

BibTeX
@article{Palmo2026,
  author = {Palmo, Tashi and Jamwal, Vishwani and Goel, Karan and Kumar, Anuj and Mujwar, Somdutt and Bharitkar, Yogesh P and Singh, Kuljit},
  title = {Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights},
  journal = {Medicinal Chemistry Research},
  year = {2026},
  volume = {35},
  number = {8},
  pages = {1529--1542},
  doi = {10.1007/s00044-026-03599-2}
}
Kostenlos starten →